These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8595140)

  • 21. Serine transhydroxymethylase: mechanism of aldolase activation by folate.
    Jones CW; Priest DG
    Arch Biochem Biophys; 1976 May; 174(1):305-11. PubMed ID: 7202
    [No Abstract]   [Full Text] [Related]  

  • 22. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
    Zhao R; Babani S; Gao F; Liu L; Goldman ID
    Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marked suppression of the activity of some, but not all, antifolate compounds by augmentation of folate cofactor pools within tumor cells.
    Zhao R; Gao F; Goldman ID
    Biochem Pharmacol; 2001 Apr; 61(7):857-65. PubMed ID: 11274972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT2 by antifolate drugs.
    Scaletti E; Jemth AS; Helleday T; Stenmark P
    FEBS Lett; 2019 Jul; 593(14):1863-1873. PubMed ID: 31127856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deaza analogs of folic acid as antitumor agents.
    Kisliuk RL
    Curr Pharm Des; 2003; 9(31):2615-25. PubMed ID: 14529545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computer modelling of antifolate inhibition of folate metabolism using hybrid functional petri nets.
    Assaraf YG; Ifergan I; Kadry WN; Pinter RY
    J Theor Biol; 2006 Jun; 240(4):637-47. PubMed ID: 16352313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New drugs in therapy of colorectal cancer: preclinical studies.
    Rustum YM; Cao S
    Semin Oncol; 1999 Dec; 26(6):612-20. PubMed ID: 10606254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of action of fluoropyrimidines: relevance to the new developments in colorectal cancer chemotherapy.
    Sobrero A; Guglielmi A; Grossi F; Puglisi F; Aschele C
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):72-7. PubMed ID: 11049035
    [No Abstract]   [Full Text] [Related]  

  • 29. The antifolates.
    Visentin M; Zhao R; Goldman ID
    Hematol Oncol Clin North Am; 2012 Jun; 26(3):629-48, ix. PubMed ID: 22520983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folate during antifolate chemotherapy: what we know... and do not know.
    Robien K
    Nutr Clin Pract; 2005 Aug; 20(4):411-22. PubMed ID: 16207681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate.
    Miyachi H; Takemura Y; Kobayashi H; Ando Y
    Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serine hydroxymethyltransferase: a key player connecting purine, folate and methionine metabolism in Saccharomyces cerevisiae.
    Saint-Marc C; Hürlimann HC; Daignan-Fornier B; Pinson B
    Curr Genet; 2015 Nov; 61(4):633-40. PubMed ID: 25893566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-folate toxicity and its reversal.
    Harrap KR
    Biochem Soc Trans; 1976; 4(5):856-9. PubMed ID: 793905
    [No Abstract]   [Full Text] [Related]  

  • 34. Antimetabolites.
    Johnston PG; Takimoto CH; Grem JL; Fidias P; Grossbard ML; Chabner BA; Allegra CJ; Chu E
    Cancer Chemother Biol Response Modif; 1997; 17():1-39. PubMed ID: 9551206
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.
    Peters GJ; Backus HH; Freemantle S; van Triest B; Codacci-Pisanelli G; van der Wilt CL; Smid K; Lunec J; Calvert AH; Marsh S; McLeod HL; Bloemena E; Meijer S; Jansen G; van Groeningen CJ; Pinedo HM
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):194-205. PubMed ID: 12084461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folate forms, functions and fate.
    Herbert V
    N Engl J Med; 1972 Jan; 286(4):214-5. PubMed ID: 4536623
    [No Abstract]   [Full Text] [Related]  

  • 37. Variable expression of RFC1 in human leukemia cell lines resistant to antifolates.
    Kobayashi H; Takemura Y; Ohnuma T
    Cancer Lett; 1998 Feb; 124(2):135-42. PubMed ID: 9500202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrier.
    Zhao R; Chattopadhyay S; Hanscom M; Goldman ID
    Clin Cancer Res; 2004 Dec; 10(24):8735-42. PubMed ID: 15623659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate metabolites as modulators of antitumor drug activity.
    Priest DG; Schmitz JC; Bunni MA
    Adv Exp Med Biol; 1993; 338():693-8. PubMed ID: 8304208
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
    Assaraf YG
    Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.